Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sermorelin side effects are mostly mild and local in the studies that exist, but nearly all of that evidence comes from children, one small trial in older adults, and an old drug label. Sermorelin is a prescription peptide, not a supplement, so treat this page as background for a talk with a licensed clinician, not a substitute for one. I am Judy, and I am not a medical professional.
Is Sermorelin FDA Approved?
No sermorelin product is marketed under an FDA approval today. The brand product Geref (sermorelin acetate, NDA 020443, EMD Serono) was approved on September 26, 1997, and Drugs@FDA now lists both Geref strengths as discontinued. The same entry says the FDA determined the product was not discontinued or withdrawn for safety or effectiveness reasons. The U.S. Anti-Doping Agency puts the discontinuation at 2008.
Geref was approved for diagnostic testing of pituitary function and for short stature in children with growth hormone deficiency, and the FDA’s own October 2024 advisory committee briefing notes that no growth hormone secretagogue has been approved to treat growth hormone deficiency in adults. Using sermorelin for anti-aging, energy or weight is off-label. What is sold today is a compounded version. USADA says it may be available by prescription from some compounding pharmacies and anti-aging or wellness clinics, and it warns that unregulated online sellers can ship contaminated or mislabeled products.
What Are the Most Common Sermorelin Side Effects?
The best-documented ones are local. The label text, as reproduced by RxList (FDA revision date October 2, 2001), says the most common treatment-related adverse event, about 1 patient in 6, was a local injection reaction. Of 350 patients exposed in the label’s clinical trials, three stopped treatment because of injection reactions. Other treatment-related events each occurred in under 1% of patients, and flushing was among them. This is old data, and the approved uses were diagnosis and children’s growth, so it tells you little about an adult taking sermorelin for other reasons.
Injection site reactions
Pain, redness or swelling where the shot goes in is the headline effect. A published review of sermorelin in children with idiopathic growth hormone deficiency (BioDrugs, 1999) calls repeated daily injections well tolerated and names transient facial flushing and injection site pain as the most commonly reported adverse events.
Flushing
Brief facial warmth or redness appears in both the label and the pediatric review. No controlled trial cited here measures how long it lasts in adults, so any timeline you see on a clinic site is a general impression, not a measured number.
What Side Effects Show Up in Adult Studies?
Human data in adults is small. One of the few controlled trials, published in the Journal of Clinical Endocrinology and Metabolism in 1997, followed 19 older adults aged 55 to 71 (10 women, 9 men). After 4 weeks of placebo, they self-injected a growth hormone releasing hormone analog (a close relative of sermorelin, not the same molecule) nightly for 16 weeks. The only adverse effect the authors reported was transient high blood fats that resolved by the end of the study. Blood pressure and body weight did not change, and skin thickness increased. It was single blind, small and short, so it cannot rule out rarer or slower problems.
Fluid retention and swelling
USADA says many users report swelling and fluid build-up in the arms, legs and face, along with joint and nerve pain. That describes reported use, not a measured rate from a controlled trial. A 2026 narrative review of growth hormone axis peptides in Frontiers in Endocrinology lists fluid retention and muscle and joint aches only for tesamorelin, a different growth hormone releasing hormone analog. For sermorelin it lists injection site pain, short-term flushing, nausea, dizziness, headache and rare allergic reaction.
Blood sugar and hormone changes
The same Frontiers review notes a small, transient prolactin rise with sermorelin. It links cortisol rises to growth hormone releasing peptides and glucose findings to tesamorelin, and warns in general that sustained stimulation of the growth hormone axis may raise insulin resistance risk. USADA adds that excess growth hormone can contribute to insulin resistance. The label also reports that in its clinical studies the incidence of hypothyroidism during treatment was 6.5%. It does not say who those patients were or whether sermorelin caused it, so do not read it as an adult rate. If you have a thyroid or blood sugar condition, this is a conversation for your prescriber and a lab test, not a guess.
Is Sermorelin Safe Long Term?
Nobody can say, because long-term human evidence in adults is missing. The Frontiers review sorts these peptides into evidence tiers and describes cancer-related concerns about stimulating the growth hormone axis as biologically plausible but unproven. USADA states that chronic growth hormone excess is linked to high blood pressure and enlarged heart muscle. Neither source shows that sermorelin at prescribed doses does this, and neither shows that it does not. The 1997 adult trial lasted 16 weeks, so it says nothing about years.
Who Should Be Careful With Sermorelin?
The label says sermorelin should not be used by anyone with a known sensitivity to sermorelin or its other ingredients, and it warns that local or systemic allergic reactions can occur with any peptide. It also notes that a large share of patients develop antibodies to the hormone at least once during treatment; the label says their significance is unclear and they do not appear to affect growth. The label lists pregnancy as Category C and says to use it in pregnancy only if the potential benefit justifies the risk to the fetus. Tell a prescriber about thyroid disease, diabetes or prediabetes, heart or blood pressure problems, any history of cancer, and every medication you take. Whether sermorelin is right for you is their call, not mine.
How Can You Lower Your Risk of Side Effects?
Use a licensed clinician who reviews your history, and a prescription filled by a licensed pharmacy. USADA specifically warns that black market and unregulated online sources may sell contaminated or mislabeled product, which is a risk separate from sermorelin itself. Ask your prescriber what labs they want before and during treatment and which symptoms should make you call.
When Should You Call Your Clinician?
Call promptly for swelling that spreads, joint or nerve pain, or any sign of an allergic reaction. Seek emergency care for a severe reaction. Do not adjust a dose on your own.
How Do You Get Sermorelin Legally?
Through a prescription from a licensed clinician, which can be an in-person visit or a telehealth visit. Our guide on how to get sermorelin walks through what intake looks like, and the sermorelin therapy overview explains what the treatment is meant to do. If you are weighing another compound that comes up in the same conversations, the NAD+ side effects page covers it with its own questions.
As of October 19, 2026, GobyMeds’ own site lists sermorelin among its treatments and says all prescriptions require a consultation with a licensed provider. If you decide a telehealth service is worth a look, GobyMeds is one option. Its site sends every product’s Get Started button to the same account sign-up page, and a provider decides whether sermorelin is appropriate for you. My GobyMeds affiliate code is MTVN25, and I may earn a commission if you sign up through this link.
GobyMeds says the sermorelin it provides is a compounded medication prepared by a licensed pharmacy. Compounded medications are not FDA-approved, a provider has to approve you before anything ships, and results vary and are not guaranteed.
Medical note: I write about this topic as a woman doing her homework, not as a doctor, pharmacist or dietitian, and this page does not diagnose or treat anything. Talk to your prescriber before starting, stopping or combining any peptide, especially if you are pregnant, breastfeeding, managing a health condition or taking medication.
Frequently Asked Questions
What are the side effects of sermorelin?
The documented ones are injection site pain, redness or swelling and facial flushing. Users also report fluid retention and joint and nerve pain. Evidence in adults is limited, so report anything unusual to your prescriber.
How long do sermorelin side effects last?
No controlled adult data cited here measures duration. In the 1997 trial of 19 older adults, the one adverse effect reported, raised blood fats, had resolved by the end of the 16 weeks. Ask your prescriber what to expect and when to call.
Are there serious side effects from sermorelin?
The label says local or systemic allergic reactions may occur with any peptide, and also states that no generalized allergic reactions to sermorelin have been reported. Blood sugar and cardiovascular risks are discussed for chronic growth hormone excess in general (USADA), not shown for sermorelin, and controlled adult evidence is lacking either way.
Is sermorelin safer than HGH?
No head-to-head trial is cited here. A 2006 editorial in Clinical Interventions in Aging argued that sermorelin’s effects are limited by negative feedback, but it reported no trial data. Treat the claim as an unproven argument.
Can sermorelin cause cancer?
No study cited here shows that it does. A 2026 review calls cancer-related concerns about stimulating the growth hormone axis biologically plausible but unproven. Tell your prescriber about any cancer history before treatment.
Do you need a prescription for sermorelin?
Yes. It is a prescription-only peptide, and compounded versions come from pharmacies on a clinician’s order. Buying from unregulated websites risks contaminated or mislabeled product, according to USADA.
Sources
- Drugs@FDA: NDA 020443, Geref (sermorelin acetate)
- FDA briefing document, Pharmacy Compounding Advisory Committee, October 29, 2024
- Sermorelin acetate label text, RxList (FDA revision date 10/2/2001)
- USADA: What should athletes know about sermorelin?
- Khorram et al., J Clin Endocrinol Metab 1997;82:1472-9
- Sermorelin in children with idiopathic growth hormone deficiency, BioDrugs 1999;12:139-57
- Performance-enhancing peptides modulating the GH-IGF1 axis, Front Endocrinol 2026;17:1822475
- Walker RF, Clin Interv Aging 2006;1(4):307-308